LAS VEGAS, Sept. 22, 2016 -- Dr. Mark Schiller, Medical Director - MYnd Analytics, will present “Disruptive Technology Gets Personal” on September 25, 2016 at the Annual Conference of the American College of Private Physicians.
The presentation will focus on the use of predictive analytics to guide medication selection. Dr. Schiller will both share his own experience with the PEER Report and present the results of four randomized, controlled, double-blind trials demonstrating the efficacy of PEER technology in improving patient outcomes.
PEER is a predictive medicine technology developed by MYnd Analytics, Inc. (OTCQB:CNSO), which combines an EEG scan of brain function with a registry of long-term outcomes for over 10,000 psychiatric patients.
About MYnd Analytics, Inc.
MYnd Analytics, Inc. (www.myndanalytics.com) provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorders. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 38,000 outcomes for over 10,000 unique patients in the PEER registry. The objective of PEER Online is to avoid trial and error pharmacotherapy, which is the dominant approach for treatment resistant patients.
To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.myndanalytics.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.
Media Contact: Lauren Jenkins ScoutComms (202) 596-5669


Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Apple Turns 50: From Garage Startup to AI Crossroads
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



